[ad_1] Strategy Concept getty The practice of business strategy is unrecognizable from what it was just a few years ago. Today, strategy at its best has become a digital-decoding, direction-setting,…
Tag: Novartis
Germany Cell and Gene Therapy Market Report 2023: Players Include Novartis, Gilead Sciences, Spark Therapeutics, Amgen and Orchard Therapeutics – ResearchAndMarkets.com
[ad_1] Germany Cell and Gene Therapy Market Report 2023: Players … WV News [ad_2] Source link
French drugmaker Sanofi looks to spin off its consumer business in India
[ad_1] French drugmaker Sanofi has initiated a process to turn its consumer healthcare business in India into a listed entity through a demerger, said people with knowledge of the matter.…
Novartis South Africa’s new head of HR joins with a passion for talent development
[ad_1] / MEDIA STATEMENT / This content is not written by Creamer Media, but is a supplied media statement. Novartis South Africa has appointed seasoned Human Resources (HR) professional Sonwabo…
Seagen’s Cancer Therapy Is Making It a Takeover Target
[ad_1] Health Novel cancer agents could shore up aging pharmaceutical portfolios for big drugmakers [ad_2] Source link
WSJ News Exclusive | Pfizer in Talks to Acquire Seagen in Deal Likely Valued at More Than $30 Billion
[ad_1] WSJ News Exclusive Deals Potential deal would help the drug company add to its lineup of cancer treatments [ad_2] Source link
Drugmakers Raise Prices on Nearly 1,000 Medicines but Show Restraint
[ad_1] Health List prices climb by 5.6% on average as new federal law aims to lower drug costs [ad_2] Source link
Drug Prices Reach New High—in the Millions
[ad_1] Several new drugs, most of them gene therapies, promise one-time treatments, but their price tags will test the health-insurance system. [ad_2] Source link
Clovis Enters Bankruptcy With Deal to Sell Cancer-Drug Candidate to Novartis
[ad_1] Clovis Oncology Inc., maker of the ovarian and prostate cancer drug Rubraca, filed for bankruptcy over the weekend with a proposed deal in hand to sell its rights to…
Europe Is Hit by Shortages of Antibiotics
[ad_1] Rising demand and supply-chain issues for manufacturers are leading to a lack of vital medicines. [ad_2] Source link